Circulating levels of ATP is a biomarker of HIV cognitive impairment
Abstract
--- - "Background: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed." - "Methods: We analyze the opening of one of the larger channels expressed by humans, pannexin-1 (Panx-1) channels, in the uninfected and HIV infected population (n = 175). We determined channel opening and secretion of intracellular second messengers released through the channel such as PGE(2) and ATP. Also, we correlated the opening of Panx-1 channels with the circulating levels of PGE(2) and ATP as well as cogntive status of the individuals analyzed." - "Findings: Here, we demonstrate that Panx-1 channels on fresh PBMCs obtained from uninfected individuals are closed and no significant amounts of PGE(2) and ATP are detected in the circulation. In contrast, in all HIV-infected individuals analyzed, even the ones under effective ART, a spontaneous opening of Panx-1 channels and increased circulating levels of PGE(2) and ATP were detected. Circulating levels of ATP were correlated with cognitive decline in the HIV-infected population supporting that ATP is a biomarker of cognitive disease in the HIV-infected population." - "Interpretation: We propose that circulating levels of ATP could predict CNS compromise and lead to the breakthroughs necessary to detect and prevent brain compromise in the HIV-infected population. (C) 2019 The Authors. Published by Elsevier B.V."
Más información
Título según WOS: | ID WOS:000512904900001 Not found in local WOS DB |
Título de la Revista: | EBIOMEDICINE |
Volumen: | 51 |
Editorial: | Elsevier |
Fecha de publicación: | 2020 |
DOI: |
10.1016/j.ebiom.2019.10.029 |
Notas: | ISI |